Therapeutic Advances in Psychopharmacology: 2022, vol: 12, issue:
1)- Carol Paton, Leslie Citrome, Emilio Fernandez-Egea, Olivia Rendora, Thomas R E Barnes. Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221110016
2)- Sarra Ateb, Taoufik Fourati, Hammadi Ben Rejeb, Dominique Januel, Noomane Bouaziz. Risperidone-induced priapism: a case report and literature review.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221113246
3)- Simon Erridge, Jess Kerr-Gaffney, Carl Holvey, Ross Coomber, Daniela A Riano Barros, Urmila Bhoskar, Gracia Mwimba, Kavita Praveen, Chris Symeon, Simmi Sachdeva-Mohan, Mikael H Sodergren, James J Rucker. Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221116240
5)- Cristiana Montemagni, Elisa Del Favero, Elena Cocuzza, Flavio Vischia, Paola Rocca. Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221122526
6)- Edward Chesney, Doga Lamper, Millie Lloyd, Dominic Oliver, Emily Hird, Philip McGuire. Acceptability of cannabidiol in patients with psychosis.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221128445
7)- Thomas Vanicek, Murray B Reed, René Seiger, Godber M Godbersen, Manfred Klöbl, Jakob Unterholzner, Benjamin Spurny-Dworak, Gregor Gryglewski, Patricia Handschuh, Clemens Schmidt, Christoph Kraus, Thomas Stimpfl, Rainer Rupprecht, Siegfried Kasper, Rupert Lanzenberger. Increased left dorsolateral prefrontal cortex density following escitalopram intake during relearning: a randomized, placebo-controlled trial in healthy humans.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221132085
8)- Sofia Pappa, Arturas Kalniunas, Hitendra Sharma, Ali Raza-Syed, Manzar Kamal, Fintan Larkin. Efficacy and safety of cariprazine augmentation in patients treated with clozapine: a pilot study.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221132087
9)- Otto Simonsson, Peter S Hendricks, Richard Chambers, Walter Osika, Simon B Goldberg. Classic psychedelics, health behavior, and physical health.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221135363
11)- Siobhan Gee, Vasco Almeida, Adam Hughes, Isabel McMullen, David Taylor. Reasons for admission to a general medical hospital for patients taking clozapine.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221136753
12)- Petr Potměšil, Lenka Kostýlková, Miloslav Kopeček. Increased amisulpride serum concentration in a patient treated with concomitant pregabalin and trazodone: a case report.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221136754
13)- Yasuhiro Mori, Hiroyoshi Takeuchi, Yuichiro Tsutsumi. Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in Japan.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221139608
14)- Abu Shafi, Alex J Berry, Harry Sumnall, David M Wood, Derek K Tracy. Synthetic opioids: a review and clinical update.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221139616
15)- Ebenezer Oloyede, Bethany Mantell, Julie Williams, Serena Lai, Sameer Jauhar, David Taylor, James H MacCabe, Robert Harland, Philip McGuire, Graham Blackman. Clozapine for treatment resistance in early psychosis: a survey of UK clinicians' training, knowledge and confidence.Therapeutic advances in psychopharmacology. 2022, 12: 20451253221141222